On September 5, 2022, Elite Pharmaceuticals, Inc., a Nevada corporation (the “Registrant”), entered into an employment agreement with Kirko Kirkov to serve as the Registrants’ Chief Commercial Officer effective September 6, 2022
You might be on to something, imanjen Nobody wants to buy Lannett right now, if they do they inherit that $600 million debt. Elite is looking good, sitting in the cat bird seat.